J&J: agreement to acquire Shockwave Medical

(CercleFinance.com) - Johnson & Johnson (J&J) announces that it has entered into a definitive agreement to acquire Shockwave Medical for $335 per share in cash, which corresponds to an enterprise value of approximately $13.
1bn, including cash. NB: cp: -1.1%, pmt: +0.4%.

This transaction is expected to strengthen J&J MedTech's position in cardiovascular intervention, one of the world's fastest-growing medical technology markets, with significant unmet patient needs.

The transaction is expected to be completed by mid-2024, subject to Shockwave's shareholder approval, applicable regulatory approvals and other customary conditions.

J&J expects it to be operationally accretive on completion, but taking into account the impact of financing costs, it is expected to dilute adjusted EPS by around $0.10 in 2024 and around $0.17 in 2025.


Copyright (c) 2024 CercleFinance.com. All rights reserved.